CANISHOT CV

Each ml contains:
Inactivated canine corona virus (CCV strain K378)

Active immunization of healthy dogs and puppies against Canine Corona Virus infection.
Prevention of CCV -associated gastroenteritis (vomiting and diarrhea).
Used in vaccination schedules in CCV endemic areas.
Aids in reducing viral shedding and environmental contamination.
Recommended as part of a comprehensive core

The vaccine contains the antigen which has been chemically inactivated, rendering it unable to cause disease. Upon injection, the inactivated virus is recognized by the canine immune system. Immune cells process the antigens and present them, stimulating the production of specific circulating neutralizing antibodies and activating cellular immunity. These antibodies are primed to neutralize the live if the animal is exposed, thereby preventing viral replication and the clinical signs of gastroenteritis.

Induces protective immunity against CCV infection.
Inactivated formulation eliminates the risk of vaccine-induced disease.
Reduces the severity and duration of clinical symptoms upon exposure.
Safe and effective for use in young puppies as per schedule.
Proven antigen content ensures reliable seroconversion.

Primary Vaccination:
dose administered subcutaneously (S.C.) or intramuscularly (IM).
Puppies typically start at 6-8 weeks, followed by boosters.
Booster: Repeat 1ml dose 3-4 weeks after the initial dose, then annually.
Follow local veterinary guidelines for specific schedules.

Single-dose Vial along with diluent.

Vaccine